A Drug-Eluting Contact Lens for Allergic Conjunctivitis

Date: 
April 18, 2022

Issue #: 

1648

Summary: 
The FDA has approved Acuvue Theravision with
Ketotifen (Johnson & Johnson Vision Care), a daily-wear,
disposable, vision-correcting soft contact
lens that releases the H1-antihistamine ketotifen, for
prevention of ocular itch due to allergic conjunctivitis
in contact lens users. This is the first approval for a
drug-eluting contact lens. Ketotifen eye drops (Alaway,
Zaditor,
and others) are available over the counter.